{"id":5237,"date":"2014-11-21T13:14:42","date_gmt":"2014-11-21T13:14:42","guid":{"rendered":"\/?p=5237"},"modified":"2014-11-21T13:17:22","modified_gmt":"2014-11-21T13:17:22","slug":"oxysure-systems-inc-otcmktsoxys-is-sick-of-being-a-sub-dollar-stock","status":"publish","type":"post","link":"\/articles\/oxysure-systems-inc-otcmktsoxys-is-sick-of-being-a-sub-dollar-stock\/","title":{"rendered":"Oxysure Systems Inc (OTCMKTS:OXYS) is Sick of Being a Sub-Dollar Stock"},"content":{"rendered":"\n

Oxysure Systems Inc (OTCMKTS:OXYS<\/a>)’s performance since the beginning of the month has been rather impressive. The total gains amount to 42% and the increasing volumes suggest that the stock is attracting more and more attention which was quite a big problem a few weeks ago. During yesterday’s session alone, OXYS<\/a> managed to add an impressive 23% and it even briefly broke through the $1 per share barrier for the first time since February 2013. Although it later slipped and closed the day at $0.95, it seems determined to exit the sub-dollar levels as soon as possible. By the looks of things, quite a lot of people are excited about OXYS<\/a><\/strong> and we should note that they have a few reasons to feel that way.<\/p>\n

Recently, OXYS<\/a><\/strong>‘ management team announced a merger between their company and an entity called Estill Medical Technologies and during a conference call, they said that according to their estimates, the deal will help them register revenues of over $10 million for the fiscal 2015. That’s quite a figure, but we should note that even without Estill on board, OXYS<\/a><\/strong> is not doing too badly. Here’s what the financial statement looked like at the end of the third quarter:<\/p>\n